AMR View AMR The economic and social value of non-prescription antimicrobial medicines for the treatment of fungal and viral infections (AESGP, 2024) November 18, 2024 Read more View AMR Health economic study on impact of reverse-switching antifungal and antiviral non-prescription medicines (IQVIA, 2024) August 01, 2024 Read more
